By Sophia Dourou ( December 11, 2025, 6:09 PM GMT) -- Abbott urged an appeals court Thursday to restore the patent for its flagship glucose monitoring device, arguing that the delay in producing the judgment that invalidated it led to "material inconsistency" in the judge's reasoning....

See Full Page